An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1).
Saved in:
| Title: | An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1). |
|---|---|
| Authors: | Asselah, Tarik1 tarik.asselah@bjn.aphp.fr, Moreno, Christophe2, Sarrazin, Christoph3, Gschwantler, Michael4, Foster, Graham R.5, Craxí, Antonio6, Buggisch, Peter7, Ryan, Robert8, Lenz, Oliver9, Scott, Jane10, Van Dooren, Gino9, Lonjon-Domanec, Isabelle11, Schlag, Michael12, Buti, Maria13 |
| Source: | PLoS ONE. 7/18/2016, Vol. 11 Issue 7, p1-15. 15p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
